Latest Ratios: P/E Ratio 16.6x · EV/EBITDA 7.0x · ROE 27.5%. (2013–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $4.6B | $2.9B | $2.3B | — | — | — | — | — | — | — | — |
| Enterprise Value | $8.4B | $6.7B | $5.9B | — | — | — | — | — | — | — | — |
| P/E Ratio → | 16.60 | 9.91 | 11.46 | — | — | — | — | — | — | — | — |
| P/S Ratio | 1.27 | 0.80 | 0.81 | — | — | — | — | — | — | — | — |
| P/B Ratio | 3.87 | 2.31 | 2.40 | — | — | — | — | — | — | — | — |
| P/FCF | 7.06 | 4.46 | 2.05 | — | — | — | — | — | — | — | — |
| P/OCF | 6.92 | 4.37 | 2.02 | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.85 | 2.05 | — | — | — | — | — | — | — | — |
| EV / EBITDA | 7.03 | 5.61 | 6.85 | — | — | — | — | — | — | — | — |
| EV / EBIT | 7.24 | 5.73 | 7.11 | — | — | — | — | — | — | — | — |
| EV / FCF | — | 10.25 | 5.19 | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 74.7% | 74.7% | 44.5% | 72.0% | 73.4% | 96.9% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | 32.0% | 32.0% | 28.9% | 29.1% | 23.0% | 8.1% | 7.5% | 2.2% | 11.8% | 7.9% | 8.0% |
| Net Profit Margin | 8.5% | 8.5% | 7.5% | 5.4% | 7.8% | 6.6% | 5.8% | 6.6% | 2.6% | 5.5% | 6.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 27.5% | 27.5% | 24.9% | 17.6% | 15.9% | 12.3% | 10.2% | 9.1% | 2.7% | 4.7% | 5.5% |
| ROA | 1.0% | 1.0% | 1.0% | 0.8% | 0.9% | 1.3% | 1.4% | 1.8% | 0.8% | 1.6% | 1.8% |
| ROIC | 9.4% | 9.4% | 9.4% | 8.2% | 5.0% | 4.2% | 7.6% | 2.3% | 9.0% | 5.1% | 5.3% |
| ROCE | 7.9% | 7.9% | 39.3% | 47.0% | 29.8% | 3.2% | 1.8% | 0.6% | 3.6% | 2.3% | 2.3% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 8.05 | 8.05 | 6.28 | 6.94 | 8.45 | 2.70 | 0.56 | 0.03 | — | — | — |
| Debt / EBITDA | 8.50 | 8.50 | 7.10 | 7.64 | 20.15 | 16.35 | 12.24 | — | — | — | — |
| Net Debt / Equity | — | 3.00 | 3.67 | 5.03 | 7.11 | 1.21 | -0.10 | -0.49 | -0.42 | -0.24 | -0.50 |
| Net Debt / EBITDA | 3.17 | 3.17 | 4.14 | 5.53 | 16.95 | 7.33 | -2.22 | — | -3.55 | -3.53 | -7.15 |
| Debt / FCF | — | 5.79 | 3.13 | 5.40 | 22.29 | 1.25 | — | — | -1.24 | — | -6.52 |
| Interest Coverage | 1.54 | 1.54 | 1.55 | 1.45 | 1.64 | 3.65 | — | — | — | — | — |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.16 | 3.16 | 1.09 | 1.07 | 1.05 | 0.89 | 2.38 | 2.58 | — | — | — |
| Quick Ratio | 3.16 | 3.16 | 1.09 | 1.07 | 1.05 | 0.89 | 2.38 | 2.58 | — | — | — |
| Cash Ratio | 0.82 | 0.82 | 0.12 | 0.09 | 0.06 | 0.15 | 2.38 | 2.58 | — | — | — |
| Asset Turnover | — | 0.10 | 0.12 | 0.13 | 0.07 | 0.16 | 0.20 | 0.21 | 0.28 | 0.29 | 0.29 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | — | — | — | — | — | — | — | — | — | — |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 1.1% | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | 35.4% | 45.5% | 7.2% | 35.4% | 41.5% | — | — | 114.3% | 97.6% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 6.0% | 10.1% | 8.7% | — | — | — | — | — | — | — | — |
| FCF Yield | 14.2% | 22.4% | 48.7% | — | — | — | — | — | — | — | — |
| Buyback Yield | 1.0% | — | — | — | — | — | — | — | — | — | — |
| Total Shareholder Yield | 2.1% | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding | — | $76M | $75M | $72M | $71M | $71M | $61M | $61M | $61M | $61M | $61M |
High leverage and liquidity
Based on reported figures, Marex trades at a P/E of 16.60, which appears to discount the firm's earnings volatility relative to peers like Interactive Brokers, suggesting that investors remain skeptical of the sustainability of current profit levels amidst shifting commodity market dynamics and interest rate environments.
The forward P/E of 12.34 implies a market expectation of earnings growth, yet the PEG ratio of 0.42 suggests the stock may be undervalued if the firm successfully scales its proprietary technology platforms. However, the wide gap between current and forward multiples indicates that the market is pricing in significant cyclical risk rather than long-term structural growth.
As reported in financial statements, Marex's ROIC has fluctuated significantly, reaching 7.5% in 2025Q4, which remains well below the levels achieved by peers like MarketAxess, suggesting that the firm's aggressive acquisition strategy has yet to yield a consistent or superior return on its invested capital base.
The volatility in ROIC, which dipped into negative territory in 2023Q4, highlights the difficulty in integrating large-scale acquisitions while maintaining operational efficiency. Investors should monitor whether the firm can improve its capital allocation discipline, as the current returns appear insufficient to justify the high debt levels utilized to fund expansion.
According to recent SEC filings, Marex's debt-to-equity ratio has climbed to 8.05 as of 2025Q4, a marked increase from historical levels, which indicates that the firm's reliance on leverage to support its clearing and market-making activities may be reaching a point that warrants closer scrutiny from risk-averse investors.
The interest coverage ratio of 1.41 suggests that debt service is becoming increasingly sensitive to interest rate fluctuations and operating income volatility. This elevated leverage profile limits the firm's ability to navigate potential market dislocations without further diluting shareholders or incurring higher financing costs.
Based on the provided data, Marex's asset turnover remains low at 0.10, reflecting the firm's role as a financial intermediary where the balance sheet is dominated by client-segregated assets rather than productive operating assets, which complicates traditional assessments of working capital efficiency and operational throughput.
The extended DSO figures, which reached 321 in 2025Q4, appear to be a structural feature of the commodity clearing business rather than a sign of poor credit management. However, the lack of transparency regarding the conversion cycle suggests that investors should focus on liquidity ratios rather than traditional turnover metrics to gauge operational health.
As indicated by the reported figures, the P/B ratio of 3.87 is frequently misapplied to Marex, as it fails to account for the massive, non-corporate client-segregated cash balances that artificially inflate the asset base and distort the firm's true valuation relative to its actual equity-generating capacity.
Analysts should prioritize ROE and net revenue margins over book value multiples, as the latter is heavily skewed by the firm's role as a custodian of client funds. Relying on P/B ignores the reality that a significant portion of the balance sheet is restricted, making it a poor indicator of the firm's intrinsic value.
Includes 30+ ratios · 13 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MRX stock.
Marex Group plc Ordinary Shares's current P/E ratio is 16.6x. The historical average is 10.7x. This places it at the 100th percentile of its historical range.
Marex Group plc Ordinary Shares's current EV/EBITDA is 7.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 6.2x.
Marex Group plc Ordinary Shares's return on equity (ROE) is 27.5%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 10.7%.
Based on historical data, Marex Group plc Ordinary Shares is trading at a P/E of 16.6x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Marex Group plc Ordinary Shares's current dividend yield is 1.14%.
Marex Group plc Ordinary Shares has 74.7% gross margin and 32.0% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Marex Group plc Ordinary Shares's Debt/EBITDA ratio is 8.5x, indicating high leverage. A ratio above 4x may signal elevated financial risk.